Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Operational Research of C-TST for Diagnosis of Latent TB Infection in Indonesia
NCT07587164Completed
- Sponsor
- Zhifei Biological
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Open-label, single-arm trial of C-Tb in latent tuberculosis infection (LTBI), sponsored by Zhifei Biological. Primary endpoint: Acceptance rate between C-TST and IGRA test at 7 days. Started May 2025; status: completed.
02
Drugs
C-Tb
03
Conditions
latent tuberculosis infection (LTBI)
Beyond the preview
Go deeper on NCT07587164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07587164.